Polychronis Kemos

About Polychronis Kemos

Polychronis Kemos, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at Queen Mary University of London, specializes in the field of Statistics, Clinical trials, RWD & Epidemiology, Statistical modelling.

His recent articles reflect a diverse array of research interests and contributions to the field:

Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry

Accuracy of an artificial intelligence as a medical device as part of a UK-based skin cancer teledermatology service

Calibrating output from an image classifier

P274 Renal failure in children with inflammatory bowel disease

Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi‐ethnic cohort

HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and …

Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn’s Disease: Real-world Data from the International …

A large-scale, multi-centre, prospective observational study to treat hepatitis C in Pakistan and assess resistance to antiviral drugs (HepFREEPak): study protocol

Polychronis Kemos Information

University

Position

___

Citations(all)

272

Citations(since 2020)

260

Cited By

98

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Polychronis Kemos Skills & Research Interests

Statistics

Clinical trials

RWD & Epidemiology

Statistical modelling

Top articles of Polychronis Kemos

Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry

The Lancet Child & Adolescent Health

2024/4/30

Accuracy of an artificial intelligence as a medical device as part of a UK-based skin cancer teledermatology service

Frontiers in Medicine

2024/3/22

Calibrating output from an image classifier

2024/3/21

P274 Renal failure in children with inflammatory bowel disease

Journal of Crohn's and Colitis

2024/1/1

Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi‐ethnic cohort

Journal of Viral Hepatitis

2024/1

Polychronis Kemos
Polychronis Kemos

H-Index: 5

HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and …

BMC Public Health

2023/12/18

Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn’s Disease: Real-world Data from the International …

Journal of Crohn's and Colitis

2023/11/27

Polychronis Kemos
Polychronis Kemos

H-Index: 5

Dimitris Rizopoulos
Dimitris Rizopoulos

H-Index: 40

A large-scale, multi-centre, prospective observational study to treat hepatitis C in Pakistan and assess resistance to antiviral drugs (HepFREEPak): study protocol

2023/9/14

Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort

Alimentary Pharmacology & Therapeutics

2023/7

Polychronis Kemos
Polychronis Kemos

H-Index: 5

BT03 (P63) Effectiveness of an image-analysing artificial intelligence-based digital health technology to diagnose nonmelanoma skin cancer and benign skin lesions

British Journal of Dermatology

2023/6

Polychronis Kemos
Polychronis Kemos

H-Index: 5

Jack Greenhalgh
Jack Greenhalgh

H-Index: 1

P243 The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naïve children with inflammatory bowel disease: an international …

Journal of Crohn's and Colitis

2023/2/1

Patient perspectives of artificial intelligence as a medical device in a skin cancer pathway

Frontiers in Medicine

2023

Khawar Hussain
Khawar Hussain

H-Index: 2

Polychronis Kemos
Polychronis Kemos

H-Index: 5

Effectiveness of an image analyzing AI-based Digital Health Technology to identify Non-Melanoma Skin Cancer and other skin lesions: results of the DERM-003 study

Frontiers in Medicine

2023

P75 Inter-ethnic differences of quantitative hepatitis B surface antigen (qHBsAg) in predicting highly viraemic pregnancy with chronic hepatitis B infection

2022/9

Polychronis Kemos
Polychronis Kemos

H-Index: 5

Patrick Kennedy
Patrick Kennedy

H-Index: 7

High impact of pediatric inflammatory bowel disease on caregivers’ work productivity and daily activities: An international prospective study

The Journal of pediatrics

2022/7/1

The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease: a prospective international cohort study based on the PIBD …

Journal of Crohn's and Colitis

2022/5/1

Polychronis Kemos
Polychronis Kemos

H-Index: 5

Corrigendum: TALPID3/KIAA0586 Regulates Multiple Aspects of Neuromuscular Patterning During Gastrointestinal Development in Animal Models and Human

Frontiers in Molecular Neuroscience

2022/4/29

P678 Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry

Journal of Crohn's and Colitis

2022/1/1

P146 Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric …

Journal of Crohn's and Colitis

2022/1/1

P045 TIGIT expression differentiates regulatory from inflammatory Th1* gut-homing effector CD4+ T cells in inflammatory bowel disease patients

Journal of Crohn's and Colitis

2022/1/1

See List of Professors in Polychronis Kemos University(Queen Mary University of London)